Remove 2022 Remove Clinic Remove Disease Remove Inpatient
article thumbnail

Don’t Forget About the IO in the Critically Ill Patient

REBEL EM

CVC vs PIV The critically ill patient is often associated with pathology that makes IV access difficult such as shock state, hypovolemia, obesity, IV drug abuse, end-stage renal disease, cardiac arrest, as well as other conditions. Clinical Management of Intraosseous Access in Adults in Critical Situations for Health Professionals.

Hospital 105
article thumbnail

Journal Scan – This Month in Other Journals, October 2022

AJNR

Patient demographics, aneurysm characteristics, surgical procedures, and clinical outcomes were analyzed. The authors examined the survival outcomes and dosimetry to critical structures in patients treated with Gamma Knife radiosurgery (GKRS) for ≥ 25 metastases in a single session or cumulatively over the course of their disease.

MRI 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pediatric UTIs: Short-Course vs. Standard-Course Antibiotics — Is It Time for a Change?

REBEL EM

Short-Course Therapy for Urinary Tract Infections in Children: The SCOUT Randomized Clinical Trial. What They Did: Study Design: Multicenter, randomized, double-blind, placebo-controlled, non inferiority clinical trial. Investigators assessed clinical outcomes via 2 in-person visits on days 11–14 and days 24–30. JAMA Pediatr.

IT 81
article thumbnail

Predictions for Healthcare AI Entering 2023

Aidoc

Backed by a stockpile of scientific research, clinical trials and critical feedback, healthcare AI has reached that inflection point where it is now primed for widespread adoption. Clinical AI Will Drastically Expand Its Reach As clinical AI continues its maturation, I predict it will touch up to 50% of providers in 2023.

article thumbnail

Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal

REBEL EM

1, 2 Phenobarbital has been studied as an alternative or adjunct to benzodiazepines with encouraging results, but primarily among inpatient services. 1, 2 Phenobarbital has been studied as an alternative or adjunct to benzodiazepines with encouraging results, but primarily among inpatient services. J Med Toxicol 2022.

Disease 76